SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 26071.
  • 2
    SchottenfeldD, FraumeniJF, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996. 6536.
  • 3
    Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 5359.
  • 4
    Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health 2000; 26: 1127.
  • 5
    Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H. Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960–1995. Scand J Work Environ Health 1997; 23: 26670.
  • 6
    Ariad S, Barchana M, Yukelson A, Geffen DB. A worrying increase in the incidence of mesothelioma in Israel. Isr Med Assoc J 2000; 2: 82832.
  • 7
    Jarvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 1999; 56: 1103.
  • 8
    IARC. Asbestos. Monographs on the evaluation of carcinogenic risk of chemicals to man, vol. 14. Lyon: IARC, 1977. 848p.
  • 9
    Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994; 51: 80411.
  • 10
    Dreyer L, Andersen A, Pukkala E. Occupation. In: Avoidable cancers in the Nordic countries. APMIS 1997; 105( Suppl 76): 6879.
  • 11
    McDonald JC, McDonald AD. Epidemiology of mesothelioma from estimated incidence. Prev Med 1977; 6: 42646.
  • 12
    Andersson M, Olsen JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer 1985; 51: 699705.
  • 13
    Janssen-Heijnen, Damhuis RAM, Klinkhamer PJJM, Schipper RM, Coebergh JWW. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of the Netherlands since 1970: a population based study. Eur J Cancer Prev 1999; 8: 3114.
  • 14
    Gennaro V, Montanaro F, Lazzarotto A, Bianchelli M, Celesia MV. Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area. Epid Prev 2000; 24: 2138.
  • 15
    IARC. Cancer incidence in five continents, vol. VII. Lyon: IARC Sci Publ, 1997.
  • 16
    Mowe G, Gylseth B, Hartveit F, Skaug V. Occupational asbestos exposure, lung-fiber concentration and latency time in malignant mesothelioma. Scand J Work Environ Health 1984; 10: 2938.
  • 17
    Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothelioma in Australia, 1945–2000. Am J Ind Med 2002; 41: 188201.
  • 18
    Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 1982; 45: 12435.
  • 19
    Andersen N, Berg K, Noer G. Mesothelioma of the pleura. Acta Tub Scand 1960; 39: 32030.
  • 20
    Semb G. Diffuse malignant mesothelioma. A clinicopathological study of 10 fatal cases. Acta Chir Scand 1963; 126: 7891.
  • 21
    Newhouse ML. A study of the mortality of workers in an asbestos factory. Br J Ind Med 1969; 26: 294301.
  • 22
    Mowe G. The history of asbestos-related diseases in Norway. Advances in modern environmental toxicology. Princeton, NJ: Princeton Scientific Publishing, 1994. 147p.
  • 23
    Carbone M, Rizzo P, Pass H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 2000; 20: 8758.
  • 24
    Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 1987; 6: 46981.
  • 25
    Ilg A, Bignon J, Valleron A. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998; 55: 7605.
  • 26
    McCaughey WTE, Kannerstein M, Churg J. Tumors and pseudotumors of the serous membranes. Atlas of tumor pathology, 2nd series, Fascicle 20. Washington, DC: Armed Forces Institute of Pathology, 1985.
  • 27
    Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspec 1999; 107: 28997.
  • 28
    Britton M. The epidemiology of mesothelioma. Semin Oncol 2002; 29: 1825.
  • 29
    Nielsen AM, Olsen JH, Madsen PM, Francis D, Almind M. Peritoneal mesotheliomas in Danish women: review of histopathologic slides and history of abdominal surgery. Acta Obstet Gynecol Scand 1994; 73: 5815.
  • 30
    Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene 2002; 21: 11419.
  • 31
    Huncharek M. Non-asbestos related diffuse malignant mesothelioma. Tumorigenesis 2002; 88: 19.